EMA — authorised 29 June 2007
- Marketing authorisation holder: RAD NEURIM PHARMACEUTICALS EEC SARL
- Status: approved
EMA authorised Melatol on 29 June 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 29 June 2007.
RAD NEURIM PHARMACEUTICALS EEC SARL holds the EU marketing authorisation.